Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHOLESTATIC LIVER DISEASE, CONTAINING ΒETA-LAPACHONE AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2022/075756
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating cholestatic liver disease, containing β-lapachone as an active ingredient, and can provide an agent for effectively preventing and treating cholestatic liver disease.

Inventors:
YOON JOO SEOG (KR)
SEO KANG SIK (KR)
HAN JEONG SU (KR)
MOON SUNG JE (KR)
LEE JUNG HOON (KR)
YOON SOO BIN (KR)
Application Number:
PCT/KR2021/013732
Publication Date:
April 14, 2022
Filing Date:
October 06, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CUROME BIOSCIENCES CO LTD (KR)
International Classes:
A61K31/353; A23L33/105; A23L33/135; A61K31/575; A61K35/745; A61K35/747; A61P1/16
Foreign References:
KR20190026687A2019-03-13
KR20060092106A2006-08-22
Other References:
SHIN SANGHEE, PARK JISOO, LI YUWEN, MIN KI NAM, KONG GYEYEONG, HUR GANG MIN, KIM JIN MAN, SHONG MINHO, JUNG MIN-SUK, PARK JONG KOO: "β-Lapachone alleviates alcoholic fatty liver disease in rats", CELLULAR SIGNALLING., ELSEVIER SCIENCE LTD., GB, vol. 26, no. 2, 1 February 2014 (2014-02-01), GB , pages 295 - 305, XP055919322, ISSN: 0898-6568, DOI: 10.1016/j.cellsig.2013.11.020
ZHAO QI, YANG RUI, WANG JING, HU DAN-DAN, LI FEI: "PPARα activation protects against cholestatic liver injury", SCIENTIFIC REPORTS, vol. 7, no. 1, 1 December 2017 (2017-12-01), XP055919323, DOI: 10.1038/s41598-017-10524-6
WANG PING, KOYAMA YUKINORI, LIU XIAO, XU JUN, MA HSIAO-YEN, LIANG SHUANG, KIM IN H., BRENNER DAVID A., KISSELEVA TATIANA: "Promising Therapy Candidates for Liver Fibrosis", FRONTIERS IN PHYSIOLOGY, vol. 7, XP055919334, DOI: 10.3389/fphys.2016.00047
See also references of EP 4023220A4
Attorney, Agent or Firm:
GHONG-GAN INTERNATIONAL PATENT LAW FIRM (KR)
Download PDF: